Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes (SUSTAIN-6) New England Journal of Medicine 104-week trial in 3,297 high-risk T2DM patients showed semaglutide reduced composite MACE by 26% versus placebo establishing cardiovascular benefit for GLP-1 receptor agonists
adults may now be considered obese under a new definition
Magnesium support: Some people benefit from magnesium (with professional advice), which can help relax the bowel and draw water into the stool
BPC-157: The Ultimate Healing Peptide for Tendons, Joints, and Gut BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a naturally occurring protein in human gastric juice
These predispositions may provide context into why some patients require higher doses, experience rapid weight loss, or report nausea more frequently
tau de telefon Introduce-ti nr